Maturation-dependent neurotoxicity of lead acetate in vitro: Implication of glial reactions

Journal of Neuroscience Research

Volumn 70, Issue 1, 2002, Pages 108-116

  Zurich, Marie Gabrielle ^a   Eskes, Chantra ^a   Honegger, Paul ^a   Bérode, Michèle ^a   Monnet Tschudi, Florianne ^a  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

Aggregating brain cell culture; Astrocyte; Development; Gliosis; Lead acetate; Microglia

Indexed keywords

LEAD ACETATE;

ANIMAL CELL; ARTICLE; ASTROCYTE; CELL MATURATION; CONTROLLED STUDY; ENZYME ACTIVITY; FETUS; GLIOSIS; MICROGLIA; NERVE CELL CULTURE; NERVE CELL DIFFERENTIATION; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; ASTROCYTES; CARBON ISOTOPES; CELL DIFFERENTIATION; CELLS, CULTURED; CHOLINE O-ACETYLTRANSFERASE; FETUS; GLIAL FIBRILLARY ACIDIC PROTEIN; GLUTAMATE DECARBOXYLASE; GLUTAMATE SYNTHASE; IMMUNOHISTOCHEMISTRY; LECTINS; NEUROGLIA; NEURONS; ORGANOMETALLIC COMPOUNDS; RATS; TELENCEPHALON; THYMIDINE;

EID: 0036786148     PISSN: 03604012     EISSN: None     Source Type: Journal    
DOI: 10.1002/jnr.10367     Document Type: Article

References (68)

1. Aschner M, Chen R, Kimelberg HK. 1991. Effects of mercury and lead on rubidium uptake and efflux in cultured rat astrocytes. Brain Res Bull 26:639-642.
2. Aschner M, Allen JW, Kimelberg HK, LoPachin KM, LoPachm RM, Streit WJ. 1999. Glial cells in neurotoxicity development. Annu Rev Pharmacol Toxicol 39:151-173.
3. Ashwell K. 1990. Microglia and cell death in the developing mouse cerebellum. Dev Brain Res 55:219-230.
4. Balasingam V, Tejada-Berges T, Wright, E, Bouckova, R, Yang VW. 1994. Reactive astrogliosis in the neonatal mouse brain and its modulation by cytokines. J Neurosci 14:846-856.
5. Balasingam V, Dickson K, Brade A, Wee Yong Voon. 1996. Astrocyte reactivity in neonatal mice: apparent dependance on the presence of reactive microglia/macrophages. Glia 18:11-26.
6. Bettoni JM, Sprenkle PM. 1991. Low level lead inhibits the human brain cation pump. Life Sci 48:2149-2156.
7. Bielarczyk H, Tamsig JL, Suszkiw JB. 1994. Perinatal low-level lead exposure and the septohippocampal cholinergic system: selective reduction of muscarinic receptors and cholineacetyltransferase in the rat septum. Brain Res 643:211-217.
8. Bouton CMLS, Hossain MA, Frelin LP, Laterra J, Pevsner J, 2001. Microarray analysis of differential gene expression in lead-exposed astrocytes. Toxicol Appl Pharmacol 176:34-53.
9. Bressler JP. Goldstein GW. 1991. Mechanisms of lead neurotoxicity. Biochem Pharmacol 41:479-484.
10. Cline HT, Witte S, Jones KW. 1996. Low lead levels stunt neuronal growth in a reversible manner. Proc Natl Acad Sci 93:9915-9920.
11. Cory-Slechta DA. 1990. Lead exposure during advanced age: alterations in kinetics and biochemical effects. Toxicol Appl Pharmacol 104:67-78.
12. Davis JM, Otto DA, Weil DE, Grant LD. 1990. The comparative developmental neurotoxicity of lead in humans and animals. Neurotoxicol Teratol 12:215-229.
13. Dietrich KN, Succop PA, Bornschein RL, Krafft KM, Berger O, Hammond PB, Buncher CR. 1990. Lead exposure and neurobehavioral development in later infancy. Environ Health Perspect 89:13-19.
14. Eng LF, Ghirnikar RS, Lee YL. 2000. Glial fibrillary acidic protein: GFAP-thirty-one years (1969-2000). Neurochem Res 25:1439-1451.
15. Epstein HT, Fenton K, Shimpach S. 1991. Lead acetate delays rapid postnatal mouse brain and body growth. Life Sci 49:1169-1172.
16. Eskes C, Honegger P, Juillerat-Jeanneret L, Monnet-Tschudi F. 2001. Microglial reaction induced by noncytotoxic methylmercury treatment leads to neuroprotection via interactions with astrocytes and IL-6 release. Glia 37:43-52.
17. Ferguson SA, Bowman RE. 1990. Effects of postnatal lead exposure on open field behavior in monkeys. Neurotoxicol Teratol 12:91-97.
18. Finkelstein Y, Markowitz ME, Rosen JF. 1998. Low-level lead-induced neurotoxicity in children: an update on central nervous system effects. Brain Res Rev 27:168-176.
19. Flurin V, Mauras Y, Le Bouil A, Krari N, Kerjan A, Allain P. 1998. Etude de l'impregation saturnine d'enfants de moins de 6 ans de la région du Mans. Presse Med 27:57-59.
20. Han S, Qiao X, Kemp FW, Bogden JD. 1997. Lead exposure at an early age substantially increases lead retention in the rat. Environ Health Perspect 105:412-417.
21. Holtzman D, De Vries C, Nguyen H, Olson JI, Bensch K. 1984. Maturation of resistance to lead encephalopathy: cellular and subcellular mechanisms. Neurotoxicology 5:97-124.
22. Holtzman D, Olson JE, De Vries C, Bensch K. 1987. Lead toxicity in primary cultured cerebral astrocytes and cerebellar granular neurons. Toxicol Appl Pharmacol 89:211-225.
23. Honegger P, Monnet-Tschudi F. 2001. Aggregating neural cell cultures. In: Fedoroff S, Richardson A, editors. Protocols for neural cell culture. Totowa, NJ: Humana Press, p 199-218.
24. Honegger P, Werffeli P. 1988. Use of aggregating cell cultures for toxicological studies. Experientia 44:817-822.
25. Hossain MA, Bouton, CML, Pevsner J, Laterra J. 2000. Induction of vascular endothelial growth factor in human astrocytes by lead. J Biol Chem 275:27874-27882.
26. Kennedy JL, Girgis GR, Rakhra GS, McEwen Nicholls D. 1983. Protein synthesis in rat brain following neonatal exposure to lead. J Neurol Sci 59:57-68.
27. Ko J, Choi DW. 1987. Quantitative determination of glutamate mediated cortical neuronal injury in cell culture by lactate dehydrogenase efflux assay. J Neurosci Methods 20:83-90.
28. Kreutzberg GW. 1996. Microglia: a sensor for pathological events in the CNS. Trends Neurosci 19:312-318.
29. Lennette DA. 1978. An improved mounting medium for immunofluorescence microscopy. J Clin Pathol 69:647-648.
30. Li P, Rossman TG. 2001. Genes upregulated in lead-resistant glioma cells reveal possible targets for lead-induced developmental neurotoxicity. Toxicol Sci 64:90-99.
31. Lindhal LS, Bird L, Legare ME, Mikeska G, Bratton GR, Tiffany-Castiglioni E. 1999. Differential ability of astroglia and neural cells to accumulate lead: dependence on cell type and on degree of differentiation. Toxicol Sci 50:236-243.
32. Little AR, O'Callaghan JP. 2001. Astrogliosis in the adult and developing CNS: is there a role for proinflammatory cytokines? Neurotoxicology 22:607-618.
33. Lowry OH, Rosenbrough NJ, Farr AL, Randall RJ. 1951. Protein measurement with the Folin phenol reagent. J Biol Chem 193:265-275.
34. Malhotra SK, Shnitka TK, Elbrink J. 1990. Reactive astrocytes-a review. Cytobios 61:133-160.
35. Mans RJ, Novelly GD. 1961. Measurement of the incorporation of radioactive amino acids into proteins by a filter paper disk method. Arch Biochem 94:48-53.
36. McCann MJ, O'Callaghan JP, Martin PM, Bertram T, Streit WJ. 1996. Differential activation of microglia and astrocytes following trimethyl tin-induced neurodegeneration. Neuroscience 72:273-281.
37. McCarthy KD, Partlow LM. 1976. Preparation of pure neuronal and non neuronal cultures from embryonic chick sympathetic ganglia: a new method based on both differential cell adhesiveness and the formation of homotypic neuronal aggregates. Brain Res 114:391-414.
38. Monnet-Tschudi F, Zurich MG, Pithon E, van Melle G, Honegger P. 1995a. Microglial responsiveness as a sensitive marker for trimethyltin (TMT) neurotoxicity. Brain Res 690:8-14.
39. Monnet-Tschudi F, Zurich MG, Riederer BM, Honegger P. 1995b. Effects of trimethyltin (TMT) on glial and neuronal cells in aggregate cultures: dependence on the developmental stage. Neurotoxicology 16: 97-104.
40. Mushak P, Davis JM, Crocetti AF, Grant LD. 1989. Prenatal and postnatal effects oflow-level exposure: integrated summary of a report to the U.S. Congress on childhood lead poisoning. Environ Res 50:11-36.
41. Nakajima K, Kohsaka S. 2001. Microglia: activation and their significance in the central nervous system. J Biochem 130:169-175.
42. O'Callaghan JP. 1991. Quantification of glial fibrillary acidic protein: comparison of slot-immunobinding assays with a novel sandwich ELISA. Neurotoxicol Teratol 13:275-281.
43. Patel AJ, Hunt A, Gordon RD, Balazs R. 1982. The activities in different neural cell types of certain enzymes associated with the metabolic compartmentation glutamate. Dev Brain Res 4:3-11.
44. Pishak MR, Phillips AT. 1979. A modified radioisotopic assay for measuring glutamine synthetase activity in tissue extracts. Anal Biochem 94:82-88.
45. Raunio S, Tähti H. 2001. Glutamate and calcium uptake in astrocytes after acute lead exposure. Chemosphere 44:355-359.
46. Schrier BK, Shuster L. 1967. A simplified radiochemical assay for choline acetyltransferase. J Neurochem 14:977-985.
47. Selvin-Testa A, Loidl CF, Lopez-Costa JJ, Lopez EM, Pecci-Saavedra J. 1994. Chronic lead exposure induces astrogliosis in hippocampus and cerebellum. Neurotoxicology 15:389-402.
48. Selvín-Testa A, Lopez-Costa JJ, Nessi de Aviñon AC, Pecci Saavedra J. 1991. Astroglial alterations in rat hippocampus during chronic lead exposure. Glia 4:384-392.
49. Silbergeld EK. 1997. Preventing lead poisoning in children. Annu Rev Public Health 18:187-210.
50. Singh AK. 1993. Age-dependent neurotoxicity in rats chronically exposed to low levels of lead: calcium homeostasis in central neurons. Neurotoxicology 14:427-428.
51. Streit WJ, Kreutzberg GW. 1988. Response of endogenous glial cells to motor neuron degeneration induced by toxic ricin. J Comp Neurol 268:248-263.
52. Streit WJ, Walter SA, Pennell NA. 1999. Reactive microgliosis. Progr Neurobiol 57:563-581.
53. Subramanian KS, Meranger JC, MacKeen E. 1983. Graphite furnace atomic spectrometry with matrix modification for determination of cadmium and lead in human urine. Anal Chem 55:1064-1067.
54. Svensson M, Eriksson NP. Aldskogius H. 1993. Evidence for activation of astrocytes via reactive microglial cells following hypoglossal nerve transection. J Neurosci Res 35:373-381.
55. 210Pb] in the cerebellum of developing rats. J Pathol 109: 45-50.
56. Thomas WE. 1992. Brain macrophages: evaluation of microglia and their functions. Brain Res Rev 17:61-74.
57. Tiffany-Castiglioni E. 1993. Cell culture models for lead toxicity in neutonal and glial cells. Neurotoxicology 14:513-536.
58. Tiffany-Castiglioni E, Zmudzki J, Bracton GR. 1986. Cellular targets of lead neurotoxicity: in vitro models. Toxicology 42:303-315.
59. Tiffany-Castiglioni E, Zmudzki J, Wu JN, Bratton GR. 1987. Effects of lead treatment on intracellular iron and copper concentrations in cultured astroglia. Metab Brain Dis 2:61-79.
60. Wilson SH, Schrier BK, Farber JL. 1972. Markers for gene expression in cultured cells from the nervous system. J Biol Chem 247:3159-3169.
61. Wingo WJ, Awapara J. 1950, Decarboxylation of L-glutamic acid by brain. J Biol Chem 187:267-271.
62. Wu VW, Schwartz JP. 1998. Cell culture models for reactive gliosis: new perspectives. J Neurosci Res 51:675-681.
63. Yong VW. 1998. Response of astrocytes and oligodendrocytes to injury. Ment Retard Dev Disabil Res Rev 4:193-199.
64. Zawia NH, Harry GJ. 1996. Developmental exposure to lead interferes with glial and neuronal differential gene expression in the rat cerebellum. Toxicol Appl Pharmacol 138:43-47.
65. Zietlow R, Dunnet SB, Fawcett JW. 1999. The effect of microglia on embryonic dopaminergic neuronal survival in vitro: diffusible signals from neurons and glia change microglia from neurotoxic to neuroprotective. Eur J Neurosci 11:1657-1667.
66. Zurich MG, Monnet-Tschudi F, Honegger P. 1994. Long-term treatment of aggregating brain cell cultures with low concentrations of lead acetate. Neurotoxicology 15:715-720.
67. Zurich M-G, Monnet-Tschudi F, Bérode M, Honegger P. 1998. Lead acetate toxicity in vitro: dependence on cell composition of the cultures. Toxicol In Vitro 12:191-196.
68. Zurich MG, Monnet-Tschudi F, Costa LG, Schilter B, Honegger P. 2002. Aggregating brain cell cultures for neurotoxicological studies. In: Tiffany-Castiglioni E, editor. In vitro neurotoxicology: principles and challenges. Tottowa, NJ: Humana Press (in press).